Annual FCF
-$28.38 M
-$23.28 M-457.29%
31 December 2021
Summary:
Statera Biopharma annual free cash flow is currently -$28.38 million, with the most recent change of -$23.28 million (-457.29%) on 31 December 2021. STAB annual FCF is now -11703.79% below its all-time high of -$240.40 thousand, reached on 31 December 2019.STAB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$801.50 K
-$633.00 K-375.67%
30 September 2022
Summary:
Statera Biopharma quarterly free cash flow is currently -$801.50 thousand, with the most recent change of -$633.00 thousand (-375.67%) on 30 September 2022. STAB quarterly FCF is now -49993.75% below its all-time high of -$1600.00, reached on 01 March 2020.STAB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$12.19 M
+$14.48 M+54.29%
30 September 2022
Summary:
Statera Biopharma TTM free cash flow is currently -$12.19 million, with the most recent change of +$14.48 million (+54.29%) on 30 September 2022. STAB TTM FCF is now -762050.00% below its all-time high of -$1600.00, reached on 01 March 2020.STAB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STAB Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | +89.3% | +57.0% |
| 5 y5 years | -10000.0% | - | - |
STAB Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -457.3% | at low | -375.7% | +94.8% | at high | +58.7% |
| 5 y | 5 years | <-9999.0% | at low | <-9999.0% | +94.8% | <-9999.0% | +58.7% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +94.8% | <-9999.0% | +58.7% |
Statera Biopharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$801.50 K(+375.7%) | -$12.19 M(-54.3%) |
| June 2022 | - | -$168.50 K(-95.5%) | -$26.68 M(-9.7%) |
| Mar 2022 | - | -$3.77 M(-49.5%) | -$29.55 M(+4.1%) |
| Dec 2021 | -$28.38 M | -$7.46 M(-51.2%) | -$28.38 M(+35.6%) |
| Sept 2021 | - | -$15.28 M(+402.8%) | -$20.92 M(+271.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$3.04 M(+17.0%) | -$5.64 M(+117.0%) |
| Mar 2021 | - | -$2.60 M(>+9900.0%) | -$2.60 M(>+9900.0%) |
| Dec 2020 | -$5.09 M(+2018.1%) | - | - |
| Mar 2020 | - | -$1600.00 | -$1600.00 |
| Dec 2019 | -$240.40 K | - | - |
FAQ
- What is Statera Biopharma annual free cash flow?
- What is the all time high annual FCF for Statera Biopharma?
- What is Statera Biopharma quarterly free cash flow?
- What is the all time high quarterly FCF for Statera Biopharma?
- What is Statera Biopharma TTM free cash flow?
- What is the all time high TTM FCF for Statera Biopharma?
What is Statera Biopharma annual free cash flow?
The current annual FCF of STAB is -$28.38 M
What is the all time high annual FCF for Statera Biopharma?
Statera Biopharma all-time high annual free cash flow is -$240.40 K
What is Statera Biopharma quarterly free cash flow?
The current quarterly FCF of STAB is -$801.50 K
What is the all time high quarterly FCF for Statera Biopharma?
Statera Biopharma all-time high quarterly free cash flow is -$1600.00
What is Statera Biopharma TTM free cash flow?
The current TTM FCF of STAB is -$12.19 M
What is the all time high TTM FCF for Statera Biopharma?
Statera Biopharma all-time high TTM free cash flow is -$1600.00